1-20 of 24
Vlastimil Scudla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Relapsed and Refractory Multiple Myeloma with Fully Oral Triplet IRD (ixazomib, lenalidomide and dexamethasone) Is Safe and with Significant Therapeutic Outcomes

Jiri Minarik, MD PhD, Petra Krhovska, Tomas Jelinek, Alexandra Jungova, Martin Mistrik, MD PhD, Tomas Pika, MD PhD, Evzen Gregora, MD, Vladimir Maisnar, MD, Jan Straub, MD, Ludek Pour, MD, Lucie Brozova, MSc, Jaroslav Bacovsky, Hana Plonkova, Pavel Jindra, MD PhD, Petr Pavlicek, MD, Jakub Radocha, MD, Ivan Spicka, MDPhDProf, Martin Stork, MD, Vlastimil Scudla, Prof, MD CSc, Roman Hajek
Journal: Blood
Blood (2018) 132 (Supplement 1): 1959.
https://doi.org/10.1182/blood-2018-99-112046
Published: 2018
Journal Articles

20 Years of Transplant Program in Multiple Myeloma - a Single Centre Experience

Jiri Minarik, MD PhD, Edgar Faber, MD, Ludek Raida, MD PhD, Tomas Szotkowski, MD, Jaroslav Bacovsky, Tomas Pika, MD PhD, Ivana Skoumalova, MD PhD, Petra Krhovska, Jana Zapletalova, Mgr., PhD, Tomas Papajik, MD prof, Vlastimil Scudla, Prof, MD CSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 5749.
https://doi.org/10.1182/blood-2018-99-112115
Published: 2018
Journal Articles

Bortezomib-Based Induction Treatment for Patients with Multiple Myeloma Ineligible for Autologous Stem Cell Transplantation: A Retrospective Multicenter Study in Czech Republic

Viera Sandecka, MD, Ludek Pour, Doc,MD PhD, Sabina Sevcikova, RNDr, PhD, Lucie Brozova, MSc, Jan Straub, MD, Vlastimil Scudla, Prof, MD CSc, Vladimir Maisnar, Prof, MD PhD, Petr Pavlicek, MD, Zdenek Adam, Prof, MD CSc, Marta Krejci, Prof, MD PhD, Martin Stork, MD, Tomas Jelinek, Hana Plonkova, Roman Hajek
Journal: Blood
Blood (2017) 130 (Supplement 1): 5435.
https://doi.org/10.1182/blood.V130.Suppl_1.5435.5435
Published: 2017
Journal Articles

Single Agent Daratumumab in Advanced Multiple Myeloma: Specific Healthcare Program in the Czech Republic

Jiri Minarik, MD PhD, Ludek Pour, MD PhD, Vladimir Maisnar, Prof, MD PhD, Ivan Spicka, MDPhD, Alexandra Jungova, MD, Hana Plonkova, Lucie Brozova, MSc, Petra Krhovska, Tomas Pika, Jaroslav Bacovsky, Sabina Sevcikova, RNDr, PhD, Jakub Radocha, MD PhD, Vlastimil Scudla, Prof, MD CSc, Roman Hájek, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5414.
https://doi.org/10.1182/blood.V130.Suppl_1.5414.5414
Published: 2017
Journal Articles

Prognostic Value of the Parameters of Myeloma Bone Disease Signaling in Patients with Newly Diagnosed Multiple Myeloma Treated with Proteasome Inhibitors

Jiri Minarik, MD PhD, Zuzana Hermanova, Jan Hrbek, Pavla Petrova, Patrik Flodr, Petra Krhovska, Tomas Pika, Jaroslav Bacovsky, Miroslav Herman, Vlastimil Scudla
Journal: Blood
Blood (2016) 128 (22): 5603.
https://doi.org/10.1182/blood.V128.22.5603.5603
Published: 2016
Journal Articles

Multiple Myeloma R-ISS Prognostic Stratification System in Real Life Population

Jakub Radocha, MD PhD, Vladimír Maisnar, MD PhD, Ludek Pour, MD PhD, Zdenek Adam, MD PhD, Ivan Spicka, MD PhD, Jan Straub, MD, Vlastimil Scudla, prof, MD PhD, Jiri Minarik, MD PhD, Evzen Gregora, MD, Petr Pavlicek, MD, Hana Frankova, MD, Lenka Zahradova, MD PhD, Alexandra Jungova, MD, Michal Sykora, MD, Petr Kessler, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Lenka Sedlarikova, MSc, Sabina Sevcikova, RNDr, PhD, Daniel Horinek, Ing, Jana Pelcova, MSc, Jiri Jarkovsky, MSc, PhD, Roman Hájek
Journal: Blood
Blood (2016) 128 (22): 3333.
https://doi.org/10.1182/blood.V128.22.3333.3333
Published: 2016
Journal Articles

Multiple Myeloma and Bone Marrow Microenvironment Immunohistochemical Study of the Expression of 15 Proteins Related to Myeloma Bone Disease

Patrik Flodr, Pavla Latalova, Petra Pusciznova, Tomas Pika, Jaroslav Bacovsky, Vlastimil Scudla, Jiri Minarik
Journal: Blood
Blood (2015) 126 (23): 5318.
https://doi.org/10.1182/blood.V126.23.5318.5318
Published: 2015
Journal Articles

Autologous Transplantation Versus Cyclophosphamide-Lenalidomide-Prednisone Followed By Lenalidomide-Prednisone Versus Lenalidomide Maintenance in Multiple Myeloma: Long-Term Results of a Phase III Trial

Francesca Gay, Valeria Magarotto, MD, Maria Teresa Petrucci, Francesco Di Raimondo, Luděk Pour, Tommaso Caravita, Vlastimil Scudla, Anna Maria Cafro, Anna Marina Liberati, Stefano Spada, Maisnar Vladimir, Norbert Pescosta, Roberto Ria, Massimo Offidani, Sara Bringhen, Annalisa Bernardini, Francesca Patriarca, Paolo Corradini, Roberto Foà, Nicola Cascavilla, Lucio Catalano, Andrew Spencer, Roman Hajek, Mario Boccadoro, MD, Antonio Palumbo
Journal: Blood
Blood (2015) 126 (23): 392.
https://doi.org/10.1182/blood.V126.23.392.392
Published: 2015
Journal Articles

Registry of Monoclonal Gammopathies (RMG) in the Czech Republic

Jakub Radocha, MD PhD, Ludek Pour, MD PhD, Ivan Spicka, MD PhD, Vlastimil Scudla, MD PhD, Evzen Gregora, MD, Hana Frankova, MD, Roman Hajek, MD, Miroslava Schutzova, MD, Michal Sykora, MD, Petr Kessler, MD, Dagmar Adamova, MD, Marek Wrobel, MD, Lenka Sedlarikova, MSc, Sabina Sevcikova, RNDr, PhD, Daniel Horinek, MSc, Jana Pelcova, Bc, Lucie Brozova, Mgr, Jiri Jarkovsky, MSc, PhD, Vladimir Maisnar, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4514.
https://doi.org/10.1182/blood.V126.23.4514.4514
Published: 2015
Journal Articles

Assessment of the Parameters of Myeloma Bone Disease Signaling to the Extent of Skeletal Involvement, Bone Mineral Turnover and Activity of Multiple Myeloma

Jiri Minarik, Zuzana Hermanova, Pavla Petrova, Jana Zapletalova, Jan Hrbek, Petra Pusciznova, Jaroslav Bacovsky, Tomas Pika, Miroslav Herman, Vlastimil Scudla
Journal: Blood
Blood (2015) 126 (23): 1754.
https://doi.org/10.1182/blood.V126.23.1754.1754
Published: 2015
Journal Articles

Prediction of Progression of Smouldering into Therapy Requiring Multiple Myeloma By Easily Accessible Clinical Factors [in 527 Patients]

Roman Hajek, Prof, MD PhD, Viera Sandecka, MD, Anja Seckinger, MD PhD, Ivan Spicka, Prof. MD PhD, Vlastimil Scudla, prof, MD PhD, Evzen Gregora, MD, Jakub Radocha, MD PhD, Lucie Brozova, Jiri Jarkovsky, Doc, RNDr., PhD, Lucie Rihova, Aneta Mikulasova, David Starostka, MD, Lenka Walterova, MD, Dagmar Adamova, MD, Petr Kessler, MD, Martin Brejcha, MD, Ivan Vonke, MD, Jarmila Obernauerova, MD, Kamila Valentova, MD, Zdenek Adam, prof, MD PhD, Jiri Minarik, MD PhD, Jan Straub, MD, Jaromir Gumulec, MD, Anthony D. Ho, Prof., MD FRCPC, Jens Hillengass, MD, Hartmut Goldschmidt, Prof, MD, Vladimir Maisnar, As Prof, MD PhD, Dirk Hose, MD
Journal: Blood
Blood (2014) 124 (21): 2071.
https://doi.org/10.1182/blood.V124.21.2071.2071
Published: 2014
Journal Articles

Analysis of CpG Island DNA Methylation of p15 INK4b and RIL in Bone Marrow Samples of Patients with Monoclonal Gammopathies

Pavla Latalova, MD, Katerina Smesny Trtkova, Ing., Lucie Navratilova, Mgr, Vlastimil Scudla, prof, MD PhD, Jiri Minarik, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5174.
https://doi.org/10.1182/blood.V124.21.5174.5174
Published: 2014
Journal Articles

Assessment of Signalling Pathways in Myeloma Bone Disease Using Selected Parameters of Bone Marow Microenvironment

Jiri Minarik, MD PhD, Patrik Flodr, MD, Tomas Pika, MD PhD, Jaroslav Bacovsky, MD PhD, Pavla Latalova, MD, Petra Pusciznova, MD, Vlastimil Scudla, prof, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5679.
https://doi.org/10.1182/blood.V124.21.5679.5679
Published: 2014
Journal Articles

Early Diagnosis of Multiple Myeloma - Project CRAB of Czech Myeloma Group(CMG)

Jan Straub, MD, Roman Hajek, Vlastimil Scudla, prof, MD PhD, Vladimir Maisnar, As Prof, MD PhD, Evzen Gregora, Miroslava Schutzova, Zdenek Adam, prof, MD PhD, Jaroslav Bacovsky, MD PhD, Ivan Spicka, Prof. MD PhD
Journal: Blood
Blood (2014) 124 (21): 5682.
https://doi.org/10.1182/blood.V124.21.5682.5682
Published: 2014
Journal Articles

Evaluation of Current Clinical Models for Risk of Progression from Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma or Related Malignancies in 2028 Persons Followed in the Czech Republic

Viera Sandecka, MD, Zdenek Adam, prof, MD PhD, Ivan Spicka, Prof. MD PhD, Vlastimil Scudla, prof, MD PhD, Evzen Gregora, MD, Vladimir Maisnar, As Prof, MD PhD, Lucie Brozova, Jiri Jarkovsky, Doc., Lucie Rihova, Aneta Mikulasova, David Starostka, MD, Lenka Walterova, MD, Dagmar Adamova, MD, Petr Kessler, MD, Martin Brejcha, MD, Ivan Vonke, MD, Jarmila Obernauerova, MD, Kamila Valentova, MD, Ludek Pour, Doc, MD PhD, Jiri Minarik, MD PhD, Jan Straub, MD, Jakub Radocha, MD PhD, Jaromir Gumulec, MD, Roman Hajek, Prof, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3376.
https://doi.org/10.1182/blood.V124.21.3376.3376
Published: 2014
Journal Articles

Subcutaneous and Intravenous Bortezomib in Multiple Myeloma Patients Has Similar Response Rates and Toxicity Profile with No Difference in the Incidence of Peripheral Neuropathy: Report of the Czech Myeloma Group

Jiri Minarik, MD PhD, Petr Pavlicek, MD, Ludek Pour, Doc, MD PhD, Tomas Pika, MD PhD, Vladimir Maisnar, As Prof, MD PhD, Ivan Spicka, prof, MD PhD, Jiri Jarkovsky, RNDr, PhD, Marta Krejci, As Prof, MD PhD, Jaroslav Bacovsky, MD PhD, Jakub Radocha, MD PhD, Jan Straub, MD, Petr Kessler, MD, Marek Wrobel, MD, Lenka Walterova, MD, Michal Sykora, MD, Jarmila Obernauerova, MD, Evzen Gregora, MD, Dagmar Adamova, MD, Jaromir Gumulec, MD, Zdenek Adam, prof, MD PhD, Vlastimil Scudla, prof, MD PhD, Roman Hajek, Prof, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2117.
https://doi.org/10.1182/blood.V124.21.2117.2117
Published: 2014
Journal Articles

The Use Of Selected Parameters Of Bone Microenvironment For The Assessment Of Skeletal Involvement and Activity In Multiple Myeloma and Monoclonal Gammopathy Of Undetermined Significance

Jiri Minarik, MD, PhD, Petra Pusciznova, MD, Pavla Petrova, MD, Miroslav Herman, prof. MD, Ph.D., Tomas Pika, MD, PhD, Jan Hrbek, MD, Jaroslav Bacovsky, MD, Ph.D., Jana Zapletalova, Vlastimil Scudla, Prof. MD, Ph.D.
Journal: Blood
Blood (2013) 122 (21): 5339.
https://doi.org/10.1182/blood.V122.21.5339.5339
Published: 2013
Journal Articles

High-Dose Therapy and Autologous Stem Cell Transplantation for Multiple Myeloma: Analysis from Registry of Monoclonal Gammopathy of Czech Myeloma Group

Roman Hajek, Prof. MD, PhD, Ivan Spicka, As. Prof. MD, PhD, Vladimir Maisnar, As. Prof. MD, PhD, Tomas Pika, MD, PhD, Evzen Gregora, MD, Lenka Zahradova, MD, PhD, Jan Straub, MD, Jakub Radocha, MD, PhD, Jiri Minarik, MD, PhD, Petr Pavlicek, MD, Marta Krejci, As. Prof. MD, PhD, Ludek Pour, MD, PhD, Zdenek Adam, Prof. MD, PhD, Vlastimil Scudla, Prof. MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4528.
https://doi.org/10.1182/blood.V120.21.4528.4528
Published: 2012
Journal Articles

Similar Efficacy of Thalidomide-Based and Bortezomib-Based Regimens In the First Relapse of 209 Multiple Myeloma Patients Previously Untreated with Novel Drugs

Marta Krejci, Evzen Gregora, Ivan Spicka, Vlastimil Scudla, Jan Straub, Jiri Minarik, Zdenek Adam, Andrea Krivanova, Ludek Pour, Lenka Zahradova, Jiri Mayer, MD, PhD, Roman Hajek
Journal: Blood
Blood (2010) 116 (21): 5027.
https://doi.org/10.1182/blood.V116.21.5027.5027
Published: 2010
Journal Articles

Combined Measurement of Plasma Cell Proliferation and Apoptosis in Multiple Myeloma.

Jiri Minarik, Vlastimil Scudla, Marta Ordeltova, Tomas Pika, Jaroslav Bacovsky, Michael Steinbach, Vipin Kumar, Brian G Van Ness
Journal: Blood
Blood (2009) 114 (22): 4884.
https://doi.org/10.1182/blood.V114.22.4884.4884
Published: 2009